NCT04056013 Vicryl Rapide Versus Nonabsorbable Suture
| NCT ID | NCT04056013 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Traumatic Lacerations |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2019-09-26 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2019-09-26 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a prospective, randomized controlled trial assessing noninferiority of Vicryl Rapide compared to nonabsorbable suture. The study will be conducted in the Community Regional Medical Center emergency department (ED). The aim of this study, then, is to prospectively determine if 3-month cosmesis for traumatic laceration repair of trunk/extremity lacerations in adult patients with Vicryl Rapide is noninferior to nonabsorbable suture.
Eligibility Criteria
Inclusion Criteria: * Patient 18-years or older * single laceration on trunk or extremity requiring suture closure * laceration length \> 2-cm * wound to be closed with simple interrupted sutures Exclusion Criteria: * High infection potential * Must have one of the following: * puncture wound * -highly contaminated * devitalized tissue requiring sharp debridement * -bite wounds * -\> 24-hours-old * Low likelihood of good cosmesis * Must have one of the following: -dehisced wound from previous wound closure * -wound * -crush wound * -soft tissue deficit limiting complete apposition of wound edges * -significant overlying macerated/abraded tissue * Underlying tendon or cartilage involvement -Wound greater than 10 cm in length * Significant wound healing problems * Must have one of the following: * keloid formers * chronic steroid use * other: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ -Inability to give written consent * Must have one of the following: * non-English or non-Spanish speaker * altered mental status * incarcerated patient * No telephone number or unlikely to return for 3-month follow-up * Must have one of the following: * homeless * psychiatric patient, * nursing home patient, * other: \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ * More than one laceration needing suture repair on trunk or extremity (i.e. appropriate to proceed if second laceration is to face/neck)
Contact & Investigator
Brian Chinnock, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT04056013 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Traumatic Lacerations. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04056013 currently recruiting?
Yes, NCT04056013 is actively recruiting participants. Contact the research team at bchinnock@fresno.ucsf.edu for enrollment information.
Where is the NCT04056013 trial being conducted?
This trial is being conducted at Fresno, United States, Fresno, United States.
Who is sponsoring the NCT04056013 clinical trial?
NCT04056013 is sponsored by University of California, San Francisco. The principal investigator is Brian Chinnock, MD at University of California, San Francisco. The trial plans to enroll 96 participants.